The survival rate for osteosarcoma, a type of bone cancer, has stagnated around 50pc for the past 45 years. This is mainly because the different subtypes of osteosarcoma are not yet fully understood, ...
Medical Xpress on MSN12d
Pioneering research identifies three subtypes of osteosarcoma for better treatmentThe survival rate for osteosarcoma, a type of bone cancer, has stagnated around 50pc for the past 45 years. This is mainly because the different subtypes of osteosarcoma are not yet fully understood, ...
Researchers have identified three distinct subtypes of osteosarcoma, a rare bone cancer, using advanced mathematical modeling ...
Therapies currently under investigation may improve osteosarcoma survival even further. For instance, mature data from the COG/POG intergroup study of MTP-PE revealed promising results.
The survival rate for osteosarcoma, a type of bone cancer, has stagnated around 50pc for the past 45 years. This is mainly because the different subtypes of osteosarcoma are not yet fully understood, ...
OMO-103 is under development for the treatment of metastatic pancreatic ductal adenocarcinoma (PDAC), advanced high-grade osteosarcoma and metastatic pancreatic cancer. The therapeutic candidate is a ...
The survival rate for osteosarcoma, a type of bone cancer, has stagnated around 50pc for the past 45 years. This is mainly because the different subtypes of osteosarcoma are not yet fully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback